newsfilter
← Latest News
GlobeNewswire·

Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026

  • Absci Corporation will report third quarter 2026 business updates & financial results before market open on Thursday, November 12, 2026.
  • A conference call to discuss results & outlook begins at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) on November 12, 2026.
  • Live audio of the webcast will be available at investors.absci.com, with an archived replay accessible after the event.
  • The company utilizes its Integrated Drug Creation platform to combine AI models with synthetic biology for rapid therapeutic design.
  • Absci's pipeline includes ABS-201™, a generative AI-designed therapeutic for pattern hair loss & endometriosis.
  • Absci is headquartered in Vancouver, WA, with AI Research Labs in New York City & Serbia, plus an Innovation Center in Switzerland.